Q4 Result FY24: AARTI DRUGS LIMITED
#englopath
#Q4_Result_For_FY24
#StockMarket
#AARTI_DRUGS_LIMITED

#Q4RESULT
Aarti drugs

#EarningsWithSwadesh | #AartiDrugs ने पेश किए मार्च तिमाही (Q4) के नतीजे (YoY)

- मुनाफा 15.7% घटकर ₹47.3 करोड़
- आय 16.5% घटकर ₹620 करोड़
- EBITDA 8.2% घटकर ₹85.8 करोड़
- EBITDA मार्जिन 12.6% से बढ़कर 13.8%

#Q4WithSwadesh #StockMarket #StocksToWatch #StocksInFocus

AARTI DRUGS LTD

Q4'24 Earnings.

#AARTIDRUGS #Q4FY24 #Q4Results

#Q4WithETNOW | Aarti Drugs Q4: PAT down 15.7% YoY, revenue declines 16.5%

#StockMarket

#aartidrugs

AARTI DRUGS LIMITED - STATEMENT OF AUDITED FINANCIAL RESULTS FOR THE QUARTER & YEAR ENDED 31st Mar' 2024 👎

AARTI DRUGS investment and trade analysis

#Aartidrugs

#Aartidrugs

🎯🎯🎯

#AARTIDRUGS | 📌 Aarti Drugs Limited (NSE: AARTIDRUGS; BSE:524348) released its audited Financial Results for Q4 and full year ending 31st March 2024. Consolidated revenue declined by 16.4% YoY in Q4 FY24, with EBITDA margin at 14.0%. Standalone revenue declined by 19.6% YoY in…

AARTI DRUGS Q4 EARNINGS

bseindia.com/xml-data/corpf…

Aarti Drugs
Axtel Industries
Inox Green Energy Services
Sah Polymers

#AARTIDRUGS #Axtel #InoxGreen #Sah
#Q4FY24 #q4 results #results #earnings #q4 #Q4withTenshares #Tenshares

#Aarti Drugs

💰 **Net Profit**
- ₹473.7M vs ₹561M (YOY)
- ₹367M (QOQ)

📈 **Revenue**
- ₹6.2B vs ₹7.42B (YOY)
- ₹6.06B (QOQ)

💹 **EBITDA**
- ₹858.1M vs ₹935.4M (YOY)

📊 **EBITDA Margin**
- 13.84% vs 12.6% (YOY)

#PriceAction #stocks #stocks towatch #trading #Telegram …

Aarti Drugs: Q4 Cons Net Profit 473.7m Rupees Vs 561m (Yoy); 367m (Qoq) || Q4 Revenue 6.2b Rupees Vs 7.42b (Yoy); 6.06b (Qoq)

Aarti Drugs: Q4 Ebitda 858.1m Rupees Vs 935.4m (Yoy) || Q4 Ebitda Margin 13.84% Vs 12.6% (Yoy)

#AARTIDRUGS all EMAs converged along with Price consolidation in tight range on low volumes. #API

Aarti Drugs Result

-YoY ↓
-QoQ ↑

#banknifty #Nifty #Nifty Bank #nifty50 #stockmarketcrash #midcapnifty #smallcap #SmallCaps #AartiDrugs

Time to consider Aarti Drugs again? Results 3rd May.
Whats your view Tar ⚡?

Chart looks good for a low risk entry with the 200WEMA (461) as a SL or for more risk averse traders below the 200EMA (493).

#AARTIDRUGS

Go through the weekly, daily candle chart and noise free Renko chart. Here you can see that Renko chart is getting positive. Below 494 DCB it will again become negative at per Renko chart.

Aarti Drugs

Emerge shortly Break Out
Await the results of Q1 24.

#AartiDRUGS

#Quarterly Results tomorrow 3-05-2024

#ValueMulticaps #stockmarkets #StockMarketindia #Quarterly Earnings #StocksToBuy #StocksToBuy

#AARTIDRUGS #ADANIGREEN #AEL #APTUS #ASIANENE #AXTEL #Britannia #CARBORUNIV #FSL #GodrejProp #GOCOLORS #HFCL #INOXWIND #INOXGREEN #JSWINFRA …

Aarti Drugs good accumulation going on, strong breakout above 570 will be fast & furious, SL 460 on weekly closing basis.